Revolution Medicines Valuation Analysis Shows 80.4% Undervaluation

요약

“DCF model estimates Revolution Medicines intrinsic value at $516.60 vs current price of $101.19”
“Analysis shows 80.4% undervaluation based on projected cash flows reaching $1.2B by 2030”
“Company scores 2/6 on valuation checks with P/B ratio of 12.29x indicating high growth expectations”

Profit ▼ Debt neutral Cash poor Valuation neutral Drawdown high Recent decline

Revolution Medicines 가치 분석, 80.4% 저평가 나타내
DCF 모델, Revolution Medicines의 내재가치를 $516.60으로 추정, 현재가 $101.19와 비교
2030년 $1.2B 도달 예상 현금흐름 기반 80.4% 저평가 나타남
기업, 가치평가에서 2/6점 획득, P/B 12.29배로 높은 성장 기대 반영

출처: simplywall.st
링크: https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/is-revolution-medicines-rvmd-pricing-fully-reflect-its-surgi

소셜 공유 미리보기(OG) 전용 페이지입니다.